SIRT3: A Potential Target of Different Types of Osteoporosis

Binjing Pan1, Chongyang Chen1, Yangting Zhao1

  • 1The First Clinical Medical College, Lanzhou University, Lanzhou, Gansu, China.

PubMed

Insights

Sirtuin 3 (SIRT3) impacts bone health by influencing osteoblasts and osteoclasts, potentially preventing osteoporosis. This review explores SIRT3

Area of Science:

  • Mitochondrial Biology
  • Bone Metabolism
  • Aging Research

Background:

  • Osteoporosis (OP) is a prevalent age-related condition characterized by reduced bone density and increased fragility.
  • Sirtuin 3 (SIRT3), a mitochondrial deacetylase, is crucial for cellular homeostasis and stress response, with potential roles in preventing age-related diseases.

Purpose of the Study:

  • To review the classification and physiological functions of Sirtuins (SIRTs).
  • To elucidate the effects of SIRT3 on osteoblasts (OBs), osteoclasts (OCs), and bone marrow mesenchymal stromal cells (BMSCs).
  • To discuss the mechanisms of SIRT3 in various types of osteoporosis, including diabetic, glucocorticoid-induced, postmenopausal, and senile OP.

Main Methods:

  • Literature review of studies on SIRT3, bone metabolism, and osteoporosis.
  • Analysis of SIRT3's role in cellular pathways regulating bone homeostasis (e.g., PGC-1α, FOXO3, SOD2, AMPK).

Main Results:

  • SIRT3 enhances osteogenic potential and osteoblastic activity by improving mitochondrial function and reducing oxidative stress.
  • SIRT3 can inhibit osteoclast differentiation through antioxidant effects and modulation of inflammatory pathways.
  • SIRT3 influences key cellular components involved in bone remodeling, including OBs, OCs, and BMSCs.

Conclusions:

  • SIRT3 plays a significant role in maintaining bone health and preventing osteoporosis through multifaceted mechanisms.
  • Targeting SIRT3 may offer therapeutic strategies for various forms of osteoporosis.
  • Further research into SIRT3's specific roles in different OP subtypes is warranted.

Related Concept Videos

Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.5K
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.9K
Bone Remodeling01:40

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.3K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.5K